Alluvi Retatrutide 40mg

Alluvi Retatrutide 40mg represents premium research-grade dual agonist peptide targeting GLP-1 and GIP receptors. This high-purity formulation comes in a 40mg pen containing 4 disposable 10mg doses with 12 needles and comprehensive instruction materials. Manufactured by Alluvi Healthcare with rigorous quality standards. Ideal for metabolic research and longevity studies. Once-weekly administration protocol. Store in refrigerator (2°C to 8°C). For subcutaneous injection only. Each box includes Certificate of Analysis.